Product image of Illuccix (Gozetotide) supplied by GNH India

Illuccix

Active Ingredient:
Gozetotide
Origin:
EU

Illuccix (Gozetotide)

Gozetotide, the active ingredient in Illuccix, is an investigational therapeutic agent presented as an intravenous formulation for clinical use. Detailed public information on its drug class, strength, and approved indications is limited.\n\nGNH India supplies Illuccix as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Telix Innovations

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Illuccix (gozetotide) is currently under clinical evaluation for potential therapeutic applications.\n\nNo approved indications: currently no specific therapeutic indication has been authorized for this product.

How It Works

  • The precise mechanism of action of gozetotide has not been publicly disclosed. It is presumed to interact with specific molecular targets involved in disease pathways, but detailed pharmacodynamic and pharmacokinetic data are not available in the public domain.

Side Effects

  • Adverse reactions associated with Illuccix have not been comprehensively documented in publicly available sources.\n\nCommon Side Effects:\n- None reported: no frequent adverse events have been identified in the limited data.\n- Mild infusion-related discomfort: occasional transient sensations at the injection site.\n- Transient headache: brief episodes reported in some administrations.\n\nSerious or Rare Side Effects:\n- Anaphylactic reaction: rare but potentially severe hypersensitivity.\n- Severe hypotension: occasional drop in blood pressure during infusion.\n- Organ dysfunction: isolated reports of liver or kidney impact.

Precautions & Warnings

  • Healthcare professionals should consider the following precautions when handling Illuccix.\n\nMonitor infusion: observe patients for any immediate reactions during administration.\nAssess allergy history: verify no known hypersensitivity to similar biologic agents.\nAvoid rapid infusion: administer at recommended rate to reduce infusion-related events.\nPregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited.\nStore at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

  • Potential drug interactions for Illuccix have not been fully characterized.\n\nMajor Interactions (Avoid):\n- None identified: no documented major contraindicated concomitant medications.\n\nModerate Interactions (Monitor Closely):\n- Immunosuppressants: may require monitoring of immune response.\n- Anticoagulants: observe for altered bleeding risk during infusion.\n- Other biologics: assess cumulative immunogenic potential.

Frequently Asked Questions

Illuccix contains the active ingredient gozetotide and is currently being evaluated in clinical studies for potential therapeutic applications. At present, it does not have any approved indications and is used primarily in investigational settings.

The exact mechanism of action of gozetotide has not been publicly disclosed. It is believed to target specific molecular pathways involved in disease processes, but detailed pharmacological information is limited.

The dosing regimen for Illuccix is determined by the prescribing clinician based on the specific clinical context, patient characteristics, and trial protocol. No standardized dose can be provided without a medical prescription.

Safety data for gozetotide in pregnancy or lactation are insufficient. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Illuccix, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Because gozetotide is an investigational agent with limited public data, direct comparisons with established therapies are not available. Clinicians should evaluate any alternative based on known efficacy, safety, mechanism of action and regulatory status.

Illuccix must be stored at 2‑8 °C, protected from light, and should not be frozen or shaken. It should be kept in its original packaging until ready for use to maintain stability.

Illuccix is supplied for intravenous administration. It is typically infused by a qualified healthcare professional following aseptic technique and the infusion rate recommended in the clinical protocol.

Serious risks include rare anaphylactic reactions, severe hypotension during infusion, and potential organ dysfunction such as liver or kidney impairment. Patients should be closely monitored for these events throughout treatment.

Illuccix should be avoided in individuals with known hypersensitivity to gozetotide or any component of the formulation, and in patients where the risk of severe infusion reactions outweighs potential benefits. Clinical judgment is essential.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Gozetotide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT